NCT00357539View on ClinicalTrials.gov

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2002

Study Completion Date

March 31, 2002

Conditions
Eye Infections, Bacterial
Interventions
DRUG

Azithromycin (T1225)

Trial Locations (1)

63009

Unité de Pharmacologie Clinique, Clermont-Ferrand

Sponsors

Lead Sponsor

Laboratoires Thea
All Listed Sponsors
lead

Laboratoires Thea

INDUSTRY